mEHT treatment could induce hsp70 protein overexpression in melanomas involving their cell membranes, which activated p53 and cyclin-dependent kinase inhibitors p21waf1 and p27kip1 to promote cell cycle arrest and tumor cell senescence. The gene discussed is CDKN1B; the disease is melanoma.